Literature DB >> 22018404

The prostate-specific antigen screening conundrum: examining the evidence.

Maureen E O'Rourke1.   

Abstract

OBJECTIVES: To review the current guidelines/recommendations and the state of evidence regarding prostate-specific antigen (PSA) screening. DATA SOURCES: Nursing and medical literature, published guidelines, and Cochrane Systematic Reviews.
CONCLUSION: Very limited evidence exists to support the widespread use of PSA screening among asymptomatic men. Some evidence exists to support its use among men in moderate- to high-risk groups. No evidence supports its use among men with life expectancies of less than 10 years. IMPLICATIONS FOR NURSING PRACTICE: Multiple guidelines and recommendations exist regarding PSA screening, and not all are in agreement. Nurses must be cognizant of the available scientific evidence upon which guidelines are based and the strength of this evidence as they apply findings in their teaching. Evaluation and application of scientific evidence facilitates informed patient/family decision-making.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018404     DOI: 10.1016/j.soncn.2011.07.003

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  1 in total

1.  Peripheral zone prostate-specific antigen density: an effective parameter for prostate cancer prediction in men receiving 5α-reductase inhibitors.

Authors:  Kyo Chul Koo; Dong Hoon Lee; Seung Hwan Lee; Byung Ha Chung
Journal:  Prostate Int       Date:  2013-09-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.